MedTrace Logo

Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery

NCT03420937 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2018-02-05

No results posted yet for this study

Summary

The aim of this project is to show, whether the use of the deep neuromuscular block in certain laparoscopic robot-assisted surgery can positively influence main physiological functions compared to the use of standard neuromuscular block. Secondary outcome is to find out whether the targeted specific reversal of neuromuscular block by sugammadex improves and fastens the post-operative recovery of the patients.

Conditions

  • Observation of Neuromuscular Block
  • Complication of Ventilation Therapy
  • Postoperative Recovery

Interventions

DRUG

Sugammadex

Deep neuromuscular block provided by rocuronium to PTC 1-2. Reversal of the block with sugammadex.

DRUG

Neostigmine, Atropin Biotika

Standard neuromuscular block provided by rocuronium to TOF-count 1-2. Reversal of the block with neostigmine.

Sponsors & Collaborators

  • Palacky University

    collaborator OTHER

  • University Hospital Olomouc

    lead OTHER

Principal Investigators

  • Karel Axmann, MD · University Hospital Olomouc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2017-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03420937 on ClinicalTrials.gov